glp 1 hba1c reduction GLP-1 and GIP–GLP-1 therapies benefits in diabetes and obesity | Gustavo Monnerat posted on the topic Frontiers | The agony and
Description
However, it is an open question whether modulating microglial phenotypes influences the cross-talking with astrocytes and neuronal survival
Heart protection in type 2 diabetes with cardiovascular disease: Ozempic has an FDA indication for reducing cardiovascular risk
The Bottom Line GLP-1 drugs are a popular and growing approach to weight management
Additionally, GLP-1RAs activate the mitogen-activated protein kinase (MAPK) pathway (Erk1/2, JNK, p38), further supporting osteoblast differentiation and bone formation, with the inhibition of MAPK signaling blocking these protective effects [119]
As this medication is newer, we continue to closely monitor the research and patient outcomes
